Acadian Asset Management
LSTA icon

Acadian Asset Management’s Lisata Therapeutics LSTA Stock Holding History

Acadian Asset Management’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13,815
Closed -$296K – 2204
2020
Q4 		$296K Buy
13,815
+3,370
+32% +$80K ﹤0.01% 1409
2020
Q3 		$282K Buy
10,445
+5,677
+119% +$180K ﹤0.01% 1335
2020
Q2 		$127K Buy
+4,768
New +$140K ﹤0.01% 1648
2019
Q3 		– Sell
-1,095
Closed -$38K – 1953
2019
Q2 		$38K Hold
1,095
– – ﹤0.01% 1524
2019
Q1 		$60K Hold
1,095
– – ﹤0.01% 1635
2018
Q4 		$58K Hold
1,095
– – ﹤0.01% 1394
2018
Q3 		$97K Hold
1,095
– – ﹤0.01% 1211
2018
Q2 		$106K Buy
1,095
+195
+22% +$13.8K ﹤0.01% 1225
2018
Q1 		$79K Buy
+900
New +$62.3K ﹤0.01% 1277

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Acadian Asset Management's LSTA Position: Q1 2021 in Review

Acadian Asset Management sold out of Lisata Therapeutics (LSTA) in Q1 2021, closing a stake of 13,815 shares — an estimated $296K sold.

Acadian Asset Management first reported a position in LSTA in Q1 2018 and held it in 9 quarters. The position peaked at $296K in Q4 2020. 32 funds tracked by Wall St. Rank hold LSTA as of Q1 2021.

  • Acadian Asset Management reported no remaining Lisata Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Acadian Asset Management sold 13,815 Lisata Therapeutics shares in Q1 2021, an estimated $296K.
  • Acadian Asset Management first reported a position in Lisata Therapeutics in Q1 2018 and held it in 9 quarters.
  • Acadian Asset Management's Lisata Therapeutics position peaked at $296K in Q4 2020.
  • 32 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2021.

Based on Acadian Asset Management's 13F filing for Q1 2021, filed 11 May 2021.